Beneficial Microbes Consultancy

I am proud to be a Scientific Committee member shaping the 2026 programme for the 19th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health showcasing the latest in microbiome science. Learn more and register here: invt.io/1txb5h2bi77

I’m attending #Probiota Americas 2025 — the leading event for the microbiome, probiotics, prebiotics, and postbiotics industries in North America! 📅 Dates: June 9-11, 2025 📍 Location: Vancouver, Canada Will you be there too? Book your spot: invt.io/1txbgynx0hp

Study in Beneficial Microbes highlighted by NutraIngredients @NutraEurope: nutraingredients.com/Article/2025/0…

In my network: for sale an *Illumina NovaSeq XPlus*. Barely used, served as a back-up. Purchased a year ago for 1.2 MEuro, goes for 660 kEuro. In case of interest, drop me a DM and I'll connect you with the company.

For my Dutch speaking followers: Gezond of gelul? De titel van een BNN/VARA programma. Ik doe mee in aflevering 6; vanaf vandaag online op NPO Start, op 12 Feb uitgezonden op NPO3: npo.nl/start/serie/ge…

Beneficial Microbes has published a new issue (Vol. 15, No. 4), which opens with #OpenAccess Opinion article “Why do clinical guidelines for probiotics differ?”. The issue also contains five research articles, two of which are in #OpenAccess. brill.ws/BM15-4_

* New Issue * No less than five #OpenAccess research articles can be found in Beneficial Microbes’ latest issue (Volume 15, No. 2). Out now! brill.ws/BM15-2_

I will be speaking on prebiotics in Salt Lake City for the IPA World Congress + #Probiota Americas 2024 on June, 10 - 12. The 2024 must attend event, will connect the business and science of the microbiome industry! I hope to see you there! bit.ly/Speakers-2024

@Winclove Congrats with the fantastic ‘grand opening ‘ yesterday!

2024 started off uniquely for us with the journey to our new home. From navigating the first days to celebrating with our Winclove family and friends, it's been a joy. Check out our video capturing the transformation to tt. Vasumweg 221! #NewBeginnings

Beneficial Microbes’ first 2024 issue, Volume 15, No. 1 is out now, with an opinion article, a research article, and a review article in #OpenAccess. See the complete issue here brill.ws/BM15-1

How probiotics work compared to drug interventions in IBS? This recent systematic review shows that both probiotic and drug interventions are able to improve the persistence of IBS symptoms: wageningenacademic.com/doi/10.3920/BM…

Data Science

This year’s battle was about "The (non-)sense of commercial #microbiome testing". The videorecording is now available at beneficialmicrobes2023.org See you again at the 11th Beneficial Microbes Conference in November 2025. Merry Christmas and a happy new year!

Beneficial Microbes’ final 2023 issue, Volume 14, No. 6 is out now, with review article “Bifidobacterium adolescentis – a beneficial microbe” by T. Leser and A. Baker in #OpenAccess. brill.ws/BM14-6

Congratulations to Thibaut Maeyens for winning this year's poster award at the @BeneMicro Conference for "Discovery of novel antimicrobial compounds by investigating the genetic potential of lactic acid bacteria". The reward is an #openaccess publication in @journal_BM 🎉

The @BeneMicro Conference is over! A big thank you to all the organisers and participants. Our table with S Todorov, one author of "Recommendations for the use of standardised abbreviations for the former Lactobacillus genera, reclassified in the year 2020" soon in #openaccess!

@ATinyGreenCell Not accessible in my country (the Netherlands 🇳🇱)

All of the Qiagen buffer recipes. Hoist the colors! 🏴‍☠️

** New Issue ** Beneficial Microbes, Volume 14, No. 5 is out now, with “A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study” by M.B. La Monica et al. in #OpenAccess. brill.ws/BM14-5

The 10th Beneficial Microbes Conference has come to an end. With fond memories of the conference itself, the networking act, and the debate on the (non-)sense of commercial microbiome testing, we're looking forward to the next event in 2025. Stay informed via our social media.

One reason may be that lactose inhibits alpha-toxin expression (4-fold) in C.perfringens, which may protect young calves against the toxicity of the toxin/pathogen. It also inhibits the total viable C.perf counts.